Luke A. Granger

King's College London

Papers

1

Total Citations

46

H-Index

1

About

Luke A. Granger is a leading researcher in molecular immunology and antibody engineering, with a primary focus on harnessing the unique immune systems of camelids to combat HIV-1. His seminal work, "Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1" (2014, 46 citations), represents a breakthrough in the quest for an HIV vaccine. Granger demonstrated that llamas, which produce heavy chain-only antibodies (HCAbs), can be immunized to elicit broadly neutralizing antibodies targeting the conserved CD4-binding site of HIV-1—a feat that had eluded conventional immunization strategies in humans and other animals. This research not only illuminated the molecular evolution of these potent antibodies but also provided a roadmap for designing novel immunogens. By leveraging the unique biology of camelids, Granger’s work has opened new avenues for developing passive immunotherapy and vaccine candidates against HIV. His contributions are pivotal for students and researchers interested in antibody discovery, viral immunology, and the translational potential of unconventional immune systems.

Research Focus

Key Achievements

1
H-Index
1
Papers
46
Total Citations
46
Avg Citations/Paper
🏆 Most Cited Paper
Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1
46 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: King's College London

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago